However, BRAFV600E was shown to induce genomic instability promoting the acquisition of additional genetic defects [32] and, in the specific context of MSS CRC, concomitant BRAF and KRAS mutation occurrence was shown to increase with colon wall invasion and metastases [28]. The gene discussed is BRAF; the disease is colorectal carcinoma.